December 29, 2016 by Chain Drug Review
Boudreaux’s, C.B. Fleet Co., Fleet, Gryphon Investors, Pedia-Lax, Phazyme, Prestige Brands Holdings, Ron Lombardi, Summer’s Eve
Supplier News

TARRYTOWN, N.Y. — Prestige Brands Holdings Inc. plans to buy over-the-counter medicine and personal care manufacturer C.B. Fleet Co. from private equity firm Gryphon Investors for $825 million in cash. Prestige Brands said Fleet’s product lineup will bring leading brands in the women’s health, gastrointestinal and pediatric care categories, and the Lynchburg, Va.-based company’s global
November 23, 2015 by Chain Drug Review
David Fox, DenTek, oral care, Prestige Brands Holdings, Ron Lombardi, TSG Consumer Partners
Supplier News

TARRYTOWN, N.Y. — Prestige Brands Holdings Inc. has agreed to acquire DenTek Oral Care Inc. from investment firm TSG Consumer Partners LLC for $225 million in cash. Prestige Brands said Monday that it expects the transaction to close during the first half of 2016, pending customary closing conditions and regulatory approvals. DenTek manufactures a wide
September 17, 2015 by Chain Drug Review
Little Remedies, Prestige Brands Holdings
Supplier News

TARRYTOWN, N.Y. — Little Remedies has expanded its infant health care lineup with Advanced Colic Relief drops. Prestige Brands Holdings Inc. said Thursday that Little Remedies Advanced Colic Relief drops are formulated with a unique mix of herbs to provide gentle relief for colicky babies. Recent studies have shown that chamomile herbal blends can reduce
May 21, 2015 by Chain Drug Review and Chain Drug Review
Dramamine, Dramamine Non-Drowsy Naturals, motion sickness medicine, Prestige Brands Holdings
Supplier News

TARRYTOWN, N.Y. — Prestige Brands Holdings Inc. has added a non-drowsy option to its Dramamine motion sickness medicine brand. Called Dramamine Non-Drowsy Naturals, the product marks the brand’s first non-drowsy offering, Prestige Brands said Thursday. Unlike ginger ale, candy and gums that people often try, Dramamine Non-Drowsy Naturals contains a clinically tested dosage of ginger for preventing and
April 23, 2015 by Chain Drug Review and Chain Drug Review
Matthew Mannelly, Prestige Brands Holdings, Ron Lombardi
Supplier News
TARRYTOWN, N.Y. — Matthew Mannelly is retiring as president and chief executive officer of Prestige Brands Holdings Inc. and will be succeeded by chief financial officer Ron Lombardi. Prestige Brands said late Wednesday that Mannelly is slated to retire on June 1. With the move, he also will be retiring from the company’s board of